Rhenman & Partners Asset Management AB
Latest statistics and disclosures from Rhenman & Partners Asset Management AB's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LLY, ABC, MDT, BSX, REGN, and represent 14.80% of Rhenman & Partners Asset Management AB's stock portfolio.
- Added to shares of these 10 stocks: HCA (+$11M), MDT (+$8.5M), TECH (+$7.5M), THC (+$6.2M), ABC (+$6.1M), SWAV (+$5.6M), OSH (+$5.4M), MRTX, IQV, REGN.
- Started 7 new stock positions in NUVL, OSH, IQV, IGMS, MRSN, TECH, RLAY.
- Reduced shares in these 10 stocks: Abiomed (-$22M), ISRG (-$12M), UNH (-$8.9M), HZNP (-$8.1M), TMO (-$6.9M), BSX (-$5.1M), CVS (-$5.0M), VRTX, CI, MCK.
- Sold out of its positions in Abiomed, GH, PGNY, HZNP.
- Rhenman & Partners Asset Management AB was a net buyer of stock by $840k.
- Rhenman & Partners Asset Management AB has $959M in assets under management (AUM), dropping by 0.36%.
- Central Index Key (CIK): 0001599882
Tip: Access up to 7 years of quarterly data
Positions held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 93 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Eli Lilly & Co. (LLY) | 3.4 | $32M | -9% | 88k | 365.84 | |
AmerisourceBergen (ABC) | 3.0 | $29M | +27% | 173k | 165.71 | |
Medtronic SHS (MDT) | 2.8 | $27M | +45% | 350k | 77.72 | |
Boston Scientific Corporation (BSX) | 2.8 | $27M | -15% | 585k | 46.27 | |
Regeneron Pharmaceuticals (REGN) | 2.8 | $27M | +15% | 37k | 721.49 | |
BioMarin Pharmaceutical (BMRN) | 2.7 | $26M | +7% | 254k | 103.49 | |
Merck & Co (MRK) | 2.5 | $24M | 215k | 110.95 | ||
Gilead Sciences (GILD) | 2.4 | $23M | 270k | 85.85 | ||
Vertex Pharmaceuticals Incorporated (VRTX) | 2.4 | $23M | -16% | 80k | 288.78 | |
Anthem (ELV) | 2.4 | $23M | +12% | 45k | 512.97 | |
Tenet Healthcare Corp Com New (THC) | 2.4 | $23M | +36% | 471k | 48.79 | |
Thermo Fisher Scientific (TMO) | 2.3 | $22M | -23% | 40k | 550.69 | |
Hca Holdings (HCA) | 2.3 | $22M | +109% | 90k | 239.96 | |
Becton, Dickinson and (BDX) | 2.2 | $21M | -2% | 83k | 254.30 | |
Setup an alertRhenman & Partners Asset Management AB will file the next quarterly 13-HR in about 2 months. Would you like to be notified? |
||||||
Abbvie (ABBV) | 2.2 | $21M | -13% | 130k | 161.61 | |
Cigna Corp (CI) | 2.1 | $21M | -17% | 62k | 331.34 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.1 | $20M | -2% | 128k | 159.31 | |
UnitedHealth (UNH) | 2.1 | $20M | -30% | 38k | 530.18 | |
Humana (HUM) | 2.1 | $20M | -11% | 39k | 512.19 | |
Pfizer (PFE) | 1.9 | $18M | 350k | 51.24 | ||
Johnson & Johnson (JNJ) | 1.8 | $18M | 100k | 176.65 | ||
Alnylam Pharmaceuticals (ALNY) | 1.8 | $17M | -2% | 73k | 237.65 | |
Biontech Se Sponsored Ads (BNTX) | 1.7 | $16M | +10% | 109k | 150.22 | |
CVS Caremark Corporation (CVS) | 1.7 | $16M | -24% | 171k | 93.19 | |
Cooper Cos Com New (COO) | 1.6 | $16M | 47k | 330.67 | ||
Inspire Med Sys (INSP) | 1.6 | $15M | -3% | 61k | 251.88 | |
McKesson Corporation (MCK) | 1.5 | $15M | -22% | 39k | 375.12 | |
Axonics Modulation Technolog (AXNX) | 1.5 | $14M | +9% | 230k | 62.53 | |
Mirati Therapeutics (MRTX) | 1.4 | $14M | +52% | 300k | 45.31 | |
Danaher Corporation (DHR) | 1.4 | $13M | -19% | 50k | 265.42 | |
Harmony Biosciences Hldgs In (HRMY) | 1.4 | $13M | 240k | 55.10 | ||
Abbott Laboratories (ABT) | 1.3 | $13M | 117k | 109.79 | ||
Edwards Lifesciences (EW) | 1.1 | $11M | +15% | 144k | 74.61 | |
Silk Road Medical Inc Common (SILK) | 1.1 | $10M | +26% | 196k | 52.85 | |
Apellis Pharmaceuticals (APLS) | 1.1 | $10M | -9% | 200k | 51.71 | |
Neurocrine Biosciences (NBIX) | 1.1 | $10M | +2% | 85k | 119.44 | |
Cytokinetics Com New (CYTK) | 1.0 | $9.9M | +3% | 216k | 45.82 | |
Shockwave Med (SWAV) | 1.0 | $9.7M | +135% | 47k | 205.61 | |
Outset Med (OM) | 1.0 | $9.3M | +5% | 360k | 25.82 | |
Iveric Bio (ISEE) | 1.0 | $9.2M | +17% | 430k | 21.41 | |
Immunocore Hldgs Ads (IMCR) | 0.9 | $8.6M | 150k | 57.07 | ||
Insulet Corporation (PODD) | 0.9 | $8.5M | 29k | 294.39 | ||
Royalty Pharma Shs Class A (RPRX) | 0.9 | $8.5M | 215k | 39.52 | ||
Privia Health Group (PRVA) | 0.9 | $8.4M | +33% | 370k | 22.71 | |
Dynavax Technologies Corp Com New (DVAX) | 0.9 | $8.3M | +6% | 784k | 10.64 | |
Biogen Idec (BIIB) | 0.9 | $8.3M | -8% | 30k | 276.92 | |
Revance Therapeutics (RVNC) | 0.8 | $8.1M | +12% | 438k | 18.46 | |
Xencor (XNCR) | 0.8 | $7.7M | 294k | 26.04 | ||
Bio-techne Corporation (TECH) | 0.8 | $7.5M | NEW | 90k | 82.88 | |
ImmunoGen (IMGN) | 0.8 | $7.4M | +36% | 1.5M | 4.96 | |
Natera (NTRA) | 0.7 | $6.6M | +106% | 165k | 40.17 | |
Intra Cellular Therapies (ITCI) | 0.7 | $6.6M | 125k | 52.92 | ||
Karuna Therapeutics Ord (KRTX) | 0.6 | $5.9M | +50% | 30k | 196.50 | |
West Pharmaceutical Services (WST) | 0.6 | $5.9M | +47% | 25k | 235.35 | |
Esperion Therapeutics (ESPR) | 0.6 | $5.6M | 900k | 6.23 | ||
Veeva Sys Cl A Com (VEEV) | 0.6 | $5.6M | 35k | 161.38 | ||
Iovance Biotherapeutics (IOVA) | 0.6 | $5.5M | +69% | 864k | 6.39 | |
Envista Hldgs Corp (NVST) | 0.6 | $5.5M | +13% | 164k | 33.67 | |
EXACT Sciences Corporation (EXAS) | 0.6 | $5.4M | +44% | 110k | 49.51 | |
Oak Street Health (OSH) | 0.6 | $5.4M | NEW | 250k | 21.51 | |
Seagen (SGEN) | 0.5 | $5.3M | 41k | 128.51 | ||
Olink Hldg Ab Sponsored Ads (OLK) | 0.5 | $4.9M | 194k | 25.38 | ||
Phreesia (PHR) | 0.5 | $4.9M | +20% | 150k | 32.36 | |
Viewray (VRAY) | 0.5 | $4.5M | 1.0M | 4.48 | ||
R1 RCM (RCM) | 0.4 | $4.1M | 378k | 10.95 | ||
Agilon Health (AGL) | 0.4 | $4.1M | 255k | 16.14 | ||
Iqvia Holdings (IQV) | 0.4 | $4.1M | NEW | 20k | 204.89 | |
Alkermes SHS (ALKS) | 0.4 | $3.9M | 150k | 26.13 | ||
Alignment Healthcare (ALHC) | 0.4 | $3.8M | +18% | 325k | 11.76 | |
Glaukos (GKOS) | 0.4 | $3.7M | 85k | 43.68 | ||
Meiragtx Holdings (MGTX) | 0.4 | $3.6M | 555k | 6.52 | ||
Teladoc (TDOC) | 0.3 | $3.1M | 130k | 23.65 | ||
Relay Therapeutics (RLAY) | 0.3 | $3.0M | NEW | 200k | 14.94 | |
Arvinas Ord (ARVN) | 0.3 | $2.9M | +70% | 85k | 34.21 | |
10x Genomics Cl A Com (TXG) | 0.3 | $2.7M | 75k | 36.44 | ||
Phathom Pharmaceuticals (PHAT) | 0.3 | $2.6M | 235k | 11.22 | ||
Sangamo Biosciences (SGMO) | 0.3 | $2.6M | 820k | 3.14 | ||
Novocure Ord Shs (NVCR) | 0.3 | $2.6M | 35k | 73.35 | ||
Nuvalent Inc-a (NUVL) | 0.2 | $2.4M | NEW | 80k | 29.78 | |
Mersana Therapeutics (MRSN) | 0.2 | $2.3M | NEW | 400k | 5.86 | |
Allogene Therapeutics (ALLO) | 0.2 | $2.1M | 340k | 6.29 | ||
G1 Therapeutics (GTHX) | 0.2 | $2.0M | 370k | 5.43 | ||
Health Catalyst (HCAT) | 0.2 | $1.9M | 180k | 10.63 | ||
Ionis Pharmaceuticals (IONS) | 0.2 | $1.9M | 50k | 37.77 | ||
Rigel Pharmaceuticals Com New (RIGL) | 0.2 | $1.8M | 1.2M | 1.50 | ||
Intellia Therapeutics (NTLA) | 0.2 | $1.7M | 50k | 34.89 | ||
Stereotaxis Com New (STXS) | 0.2 | $1.7M | 797k | 2.07 | ||
Intuitive Surgical Com New (ISRG) | 0.1 | $1.3M | -90% | 5.0k | 265.35 | |
Nektar Therapeutics (NKTR) | 0.1 | $1.2M | 550k | 2.26 | ||
Nkarta (NKTX) | 0.1 | $1.2M | 200k | 5.99 | ||
Essa Pharma Com New (EPIX) | 0.1 | $945k | 375k | 2.52 | ||
Igm Biosciences (IGMS) | 0.1 | $851k | NEW | 50k | 17.01 | |
Rapid Micro Biosystems Class A Com (RPID) | 0.0 | $339k | 300k | 1.13 |
Past Filings by Rhenman & Partners Asset Management AB
SEC 13F filings are viewable for Rhenman & Partners Asset Management AB going back to 2013
- Rhenman & Partners Asset Management AB 2022 Q4 filed Feb. 13, 2023
- Rhenman & Partners Asset Management AB 2022 Q3 filed Nov. 14, 2022
- Rhenman & Partners Asset Management AB 2022 Q2 filed Aug. 12, 2022
- Rhenman & Partners Asset Management AB 2022 Q1 filed May 13, 2022
- Rhenman & Partners Asset Management AB 2021 Q4 filed Feb. 11, 2022
- Rhenman & Partners Asset Management AB 2021 Q3 filed Nov. 12, 2021
- Rhenman & Partners Asset Management AB 2021 Q2 filed Aug. 13, 2021
- Rhenman & Partners Asset Management AB 2021 Q1 filed May 14, 2021
- Rhenman & Partners Asset Management AB 2020 Q4 filed Jan. 19, 2021
- Rhenman & Partners Asset Management AB 2020 Q3 filed Oct. 13, 2020
- Rhenman & Partners Asset Management AB 2020 Q2 filed July 16, 2020
- Rhenman & Partners Asset Management AB 2020 Q1 filed April 16, 2020
- Rhenman & Partners Asset Management AB 2019 Q4 filed Jan. 17, 2020
- Rhenman & Partners Asset Management AB 2019 Q3 filed Oct. 16, 2019
- Rhenman & Partners Asset Management AB 2019 Q2 filed July 22, 2019
- Rhenman & Partners Asset Management AB 2019 Q1 filed April 11, 2019